本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Eterna Therapeutics Inc.

7.12
+0.39005.79%
盤後6.95-0.1700-2.39%19:59 EDT
成交量:45.79萬
成交額:325.68萬
市值:830.32萬
市盈率:-0.23
高:7.59
開:7.55
低:6.73
收:6.73
52周最高:71.50
52周最低:3.18
股本:116.62萬
流通股本:66.87萬
量比:0.09
換手率:68.48%
股息:- -
股息率:- -
每股收益(TTM):-30.4836
每股收益(LYR):-55.8903
淨資產收益率:-2505.61%
總資產收益率:-81.20%
市淨率:1.21
市盈率(LYR):-0.13

資料載入中...

2026/07/03

重要事件披露

Form 8-K - Current report
2026/07/03

重要事件披露

Form 8-K - Current report
2026/06/26

重要事件披露

Form 8-K - Current report
2026/05/20

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/04

重要事件披露

Form 8-K - Current report
2026/03/27

SEC問詢函

Form CORRESP - Correspondence
2026/03/20

重要事件披露

Form 8-K - Current report
2026/03/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/11

重要事件披露

Form 8-K - Current report
2026/02/05

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/02/04

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/02/04

SEC問詢函

Form CORRESP - Correspondence
2026/02/04

SEC問詢函

Form CORRESP - Correspondence